Skip to content

Is Osteopathic Manipulative Treatment (OMT) Beneficial for Elderly Patients Hospitalized With Pneumonia?

Multicenter Osteopathic Pneumonia Study in the Elderly (MOPSE)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00258661
Acronym
MOPSE
Enrollment
406
Registered
2005-11-28
Start date
2004-03-31
Completion date
2007-04-30
Last updated
2018-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Keywords

Pneumonia, Osteopathic, Manipulation, Multi-center, Elderly

Brief summary

Osteopathic Manipulative Treatment (OMT) were used in the 1800s and 1900s to treat pneumonia before the introduction of antibiotics in the mid-1900s. The purpose of this study is to determine if OMT, when used in conjunction with antibiotics and other usual care, will improve the recovery of elderly pneumonia patients.

Detailed description

This study is a multi-center study conducted across five sites in the United States to determine the efficacy of combining Osteopathic Manipulative Treatment(OMT)with antibiotics as a treatment regimen for elderly patients with pneumonia. The study is a prospective, randomized, controlled clinical trial, in which 360 subjects will be randomly assigned to three different groups to test the primary hypothesis that the combination of OMT and antibiotics will decrease the length of hospital stay for elderly patients with pneumonia. The first group (OMT Group) will receive a series of eight osteopathic manipulative techniques in combination with conventional antibiotic care. The second group (Light Touch Control Group) will receive a light touch mimic treatment in combination with conventional antibiotic care to control for the doctor-patient interaction. The third group (Conventional Care Only Group) will receive only the conventional antibiotic care normally given to elderly patients with pneumonia. The first two groups will receive two 15-20 minute treatments per day, at least six hours apart, for the duration of their stay in the acute care facility. The primary outcomes for measuring efficacy are: Length of Hospital Stay, Time to Clinical Stability, and Rate of Symptomatic and Functional Recovery. The secondary outcomes are: duration of IV and oral antibiotic usage in the hospital, number of complications and deaths secondary to pneumonia, re-admission rate within 60 days of hospitalization admission date, duration and severity of fever, duration and severity of leukocytosis, and patient satisfaction.

Interventions

PROCEDUREOsteopathic Manipulative Treatment

In addition to conventional treatment for pneumonia, a 10-minute standardized OMT protocol + 5-minute nonstandardized component was performed twice daily for the duration of hospitalization.

PROCEDURELight-touch Treatment

In addition to conventional treatment for pneumonia, a 10-minute standardized light-touch protocol (designed to mimic OMT standardized protocol) + 5-minute auscultation of carotid bruits, heart, and lungs was performed twice daily for the duration of hospitalization.

Sponsors

Brentwood Foundation
CollaboratorOTHER
Colorado Springs Osteopathic Foundation
CollaboratorOTHER
Foundation for Osteopathic Health Services (Maryland)
CollaboratorUNKNOWN
Muskegon General Osteopathic Foundation (Michigan)
CollaboratorUNKNOWN
Northwest Oklahoma Osteopathic Foundation (Oklahoma)
CollaboratorUNKNOWN
Osteopathic Founders Foundation (Oklahoma)
CollaboratorUNKNOWN
Osteopathic Institute of the South (Georgia)
CollaboratorUNKNOWN
Osteopathic Heritage Foundations
CollaboratorOTHER
Quad City Osteopathic Foundation (Iowa)
CollaboratorUNKNOWN
A.T. Still University of Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 50 Years old or older * Subject is hospitalized in an acute care facility * Subject must exhibit at least two of the classic symptoms of pneumonia, to include: * Respiration Rate greater than or equal to 25 respirations per minute * New or increased cough * Fever greater than or equal to 100.4 degrees F (38 degrees C) * Pleuritic chest pain * Worsening of mental or functional status * Leukocytosis (WBC greater than 12,000 cells per cubic millimeter) * New or increased physical findings (rales, wheezing, bronchial breath sounds)

Exclusion criteria

* Lung abscess * Advancing pulmonary fibrosis * Bronchiectasis * Pulmonary tuberculosis * Lung Cancer * Metastatic malignancy * Uncontrolled metabolic bone disease that places subject at risk for pathologic bone fracture (i.e. Paget's Disease or hypoparathyroidism) * Acute or unhealed rib or vertebral fracture * History of pathologic bone fracture * Previous participants as subject in the study * Respiratory failure (intubation)

Design outcomes

Primary

MeasureTime frameDescription
Length of Hospital StayEnd of hospital stayNumber of days from admission order to discharge order
Time to Clinical StabilityDaily for the duration of the hospital stayHalm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN, Obrosky DS, et al.: Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 1998, 279:1452-1457
Symptomatic and Functional Recovery Score14, 30, and 60 days post-admissionMetlay JP, Fine MJ, Schulz R, Marrie TJ, Coley CM, Kapoor WN, et al.: Measuring symptomatic and functional recovery in patients with communityacquired pneumonia. J Gen Intern Med 1997, 12:423-430

Secondary

MeasureTime frame
Duration and severity of leukocytosis
Duration of IV and oral antibiotic usage in the hospital
Patient Satisfaction
Number of complications and deaths secondary to pneumonia
Duration and severity of fever

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026